Home : Medical Dermatology Therapy Online Series
Medical Dermatology Therapy Online Series
Medical Dermatology Therapy Online Series will provide an opportunity to update your knowledge and understanding of both traditional and new therapeutic strategies for a range of critically important medical dermatologic conditions, including rheumatology-dermatology overlap diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria, sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
Webcasts
Release Date: July 20, 2022
Expiration Date: July 20, 2024
Estimated Time: 1 hours
Type: Webcast
Technical Requirements: none
Specialties: Dermatology, Immunology, Rheumatology, Oncology, Internal Medicine
Release Date: July 20, 2022
Expiration Date: July 20, 2024
Estimated Time: 1 hour
Type: Webcast
Technical Requirements: none
Specialties: Dermatology, Immunology, Rheumatology, Oncology, Internal Medicine
Release Date: July 20, 2022
Expiration Date: July 20, 2024
Estimated Time: 1 hour
Type: Webcast
Technical Requirements: none
Specialties: Dermatology, Immunology, Rheumatology, Oncology, Internal Medicine
Release Date: July 20, 2022
Expiration Date: July 20, 2024
Estimated Time: 1 hour
Type: Webcast
Technical Requirements: none
Specialties: Dermatology, Immunology, Rheumatology, Oncology, Internal Medicine
Interprofessional Approach to Patients on Biologics with a Focus on Psoriatic Disease
Florian Rieder, MD,
Margaret Bobonich, CNP, DNP,
Neil Korman, MD, PhD,
Elizabeth Kirchner, MSN, DNP,
Rula Hajj-Ali, MD,
Sean Krohn, PharmD,
Kristine Duly, PharmD,
Colleen Brass, LPN
Release Date: July 20, 2022
Expiration Date: July 20, 2024
Estimated Time: 2 hour
Type: Webcast
Technical Requirements: none
Specialties: Dermatology, Immunology, Rheumatology, Oncology, Internal Medicine
Series Learning Objectives
- Describe recent advances in biologic and small-molecule inhibitor drug development for immune-mediated and malignant dermatologic diseases.
- Describe updates in traditional treatment options, both skin-directed and systemic, for medical dermatologic diseases.
- Summarize updates in the pathogenesis of various medical dermatologic diseases and how this relates to both drug development and use of traditional and modern therapeutic options.
- Illustrate ocular, pulmonary, oral, and articular manifestations that may be found in patients with rheumatologic-dermatologic overlap diseases.
- Critically appraise the safety and efficacy of various adjunct therapeutic strategies for patients taking biologic or small molecule inhibitor medications.
- Review the current knowledge of the impact of systemic treatment for moderate-to-severe psoriasis on future cardiovascular health.
- Summarize the importance of an interprofessional team approach for optimal care of patients with complex medical dermatologic diseases, and provide examples of effective team workflows.
Target Audience
This course is designed for physicians, pharmacists, nurses, advanced practice clinicians, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH